[1] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
[2] |
LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao.
Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
|
[3] |
HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun.
Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507.
|
[4] |
HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang.
Comparison of calculation results of five population pharmacokinetic analysis tools
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535.
|
[5] |
LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua.
Research progress in population pharmacokinetics of rituximab
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 468-474.
|
[6] |
YAN Qiangyong, XIANG Daxiong, ZHU Ronghua, YANG Lingfeng, YANG Xiding, LI Jingjing, FAN Xiao, LIU Sai, XIONG Shoujun, FANG Pingfei.
Bioequivalence study of cinacalcet hydrochloride tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 171-177.
|
[7] |
LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang.
Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
|
[8] |
ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi.
Interactions and clinical significance of gut microbiota and levothyroxine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314.
|
[9] |
LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke.
A bioequivalence study of generic and brand clozapine in schizophrenic patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130.
|
[10] |
WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan.
Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145.
|
[11] |
MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling.
Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
|
[12] |
DAI Jingyi, WANG Jingjing, ZHANG Jing, YU Jicheng, LI Nanyang, HUANG Zhiwei.
Clinical application and research progress of inhaled methoxyflurane
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 808-813.
|
[13] |
LIU Yizhen, REN Lingxuan, YANG Jianjun, HE Jianyu, LIU Xiaojun, WANG Long, LIN Rong.
Study on the screening of active constituents of Taohong Siwu Decoction and the protective effect of ferulic acid on myocardial injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 505-515.
|
[14] |
PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin.
Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525.
|
[15] |
WU Juan, WANG Zhiqiang, ZHOU Renpeng, YANG Jingjing, QIN Huiling, ZHANG Qian, LU Chao, HU Wei.
Bioequivalence trial of fasting oral sorafenib tosylate tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 281-286.
|